Potential legal and legislative battles are sure to dominate Johnson & Johnson’s talcum powder litigation in 2025.

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 17,570,000 ...

Andrew Curtin said his wife's death after being diagnosed with mesothelioma was a result of using the company's talc-based ...